Ngā hua rapu - Friberg, Gregory

Efficacy and Safety of Bevacizumab Plus Erlotinib for Patients with Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancer: A Trial of the Chicago, PMH, and California Ph... mā Nimeiri, Halla S., Oza, Amit M., Morgan, Robert J., Friberg, Gregory, Kasza, Kristen, Faoro, Leonardo, Salgia, Ravi, Stadler, Walter M., Vokes, Everett E., Fleming, Gini F.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia mā Kantarjian, Hagop M., Schuster, Michael W., Jain, Nitin, Advani, Anjali, Jabbour, Elias, Gamelin, Erick, Rasmussen, Erik, Juan, Gloria, Anderson, Abraham, Chow, Vincent F., Friberg, Gregory, Vogl, Florian D., Sekeres, Mikkael A.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors mā Carducci, Michael, Shaheen, Montaser, Markman, Ben, Hurvitz, Sara, Mahadevan, Daruka, Kotasek, Dusan, Goodman, Oscar B., Rasmussen, Erik, Chow, Vincent, Juan, Gloria, Friberg, Gregory R., Gamelin, Erick, Vogl, Florian D., Desai, Jayesh

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Opportunities and Challenges in Implementation of Multiparameter Single Cell Analysis Platforms for Clinical Translation mā Keating, Susan M., Taylor, D. Lansing, Plant, Anne L., Litwack, E. David, Kuhn, Peter, Greenspan, Emily J., Hartshorn, Christopher M., Sigman, Caroline C., Kelloff, Gary J., Chang, David D., Friberg, Gregory, Lee, Jerry S. H., Kuida, Keisuke

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa